Tradestie Institutional Equity Comparison Engine

PMI vs TCMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TCMD Overall Edge

TCMD Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Options & Structure while PMI counters with relative strength in Momentum & Technical. Fundamentally, PMI trades at N/M Forward P/E with -248.1% operating margin (+38.6% YoY revenue) versus TCMD at 17.7x Forward P/E and 9.4% operating margin (+7.1% YoY). In options structure, PMI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TCMD
PMI N/M vs TCMD 17.7x Fwd P/E
Growth & Margin Winner TCMD
Op Margin -248.1% vs 9.4% ยท YoY +38.6% vs +7.1%
Momentum & Technical Winner PMI
1Y +107.2% vs +12.1% ยท 52W Pos 34% vs 32%
Options & Structure Winner TCMD
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (15th %ile IV)
PMI NYSE American
Picard Medical, Inc.
Surgical & Medical Instruments & Apparatus
$6.30
-2.17% 1D
Market Cap $17.1M
1M Return -34.58%
1Y Return +107.24%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 39.0 Fund 45.0 Flow 50.0 Mom 50.0
TCMD NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$25.99
-1.63% 1D
Market Cap $587.6M
1M Return +11.64%
1Y Return +12.07%
Forward P/E 17.7x
Unified AI Score
36.5 / 100 SELL
Tech 30.0 Fund 40.0 Flow 66.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PMI +107.24% TCMD +12.07% Spread: +135.96 pp (PMI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PMI Revenue TCMD Revenue PMI Op. Margin TCMD Op. Margin Margin Edge
FY2018 N/A $140M N/A 2.1% TCMD
FY2019 N/A $190M N/A 5.5% TCMD
FY2020 N/A $190M N/A -1.9% TCMD
FY2021 N/A $210M N/A -0.8% TCMD
FY2022 N/A $250M N/A -5.2% TCMD
FY2023 N/A $270M N/A 6.6% TCMD
FY2024 $0M $290M -312.3% 7.6% TCMD
FY2025 $0M $330M -268.4% 8.9% TCMD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PMI (4) vs TCMD (6)
Institutional Metric PMI TCMD Criterion Row Winner
Market Capitalization Scale $17.1M $587.6M Larger Scale TCMD
Trailing P/E Ratio Valuation 2.9x 25.5x Lower Multiple PMI
Forward P/E Ratio Valuation N/M 17.7x Lower Multiple TCMD
Revenue Growth (YoY) Growth +38.6% +7.1% Higher Growth PMI
Operating Margin (TTM) Profitability -248.1% 9.4% Higher Margin TCMD
Net Profit Margin Profitability 0.0% 6.7% Higher Margin TCMD
Return on Equity (ROE) Capital Efficiency 0.0% 11.0% Higher ROE TCMD
52-Week Range Position Momentum 34% ($0โ€“$18) 32% ($21โ€“$38) Stronger Trend PMI
Beta / 30D Volatility Risk Regime 54.06ฮฒ ยท 134% Vol 0.99ฮฒ ยท 52% Vol Lower Realized Risk TCMD
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 36.5 / 100 (SELL) Higher Composite PMI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PMI vs TCMD Buy Guide
PMI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PMI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TCMD CONSOLIDATION
97d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live TCMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PMI nor TCMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.